View Alert


Originator: MHRA Drug Alerts

 
From: Himal Makwana

Issue date: 14-Jan-2020 10:59:34

Action by recipients:
  • NHS Regional Offices
  • NHS Foundation Trusts (England) - Medical Director
  • NHS Trusts (England) - Medical Director
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Regional Directors of Public Health

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Director of Public Health
  • NHS Trusts (England) - Chief Executive
  • GP - Locum
  • NHS 111 and Out of hours providers
  • Dispensing GP Practices
  • GP Practices
  • Primary Care Networks

Action category: Class 4: For information

Title: CLASS 4 DRUG ALERT, FOR INFORMATION, ADVANZ PHARMA, ZAPAIN 30MG/500MG TABLETS (CODEINE PHOSPHATE / PARACETAMOL)

Broadcast content:
Advanz Pharma has informed the MHRA of a discrepancy on the product packaging for Zapain 30mg/500mg Tablets (Codeine Phosphate/Paracetamol). The discrepancy relates to 'capsules' printed at the top right of the packs in error, instead of tablets. Healthcare professionals are advised to exercise caution. There is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled.

Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.


Additional information: NHS England Regional Offices: Please cascade this alert to community pharmacy.
GP Practices: Please note that this alert is only relevant to Dispensing GP Practices.


Alert reference: EL (20)A/01

Attachments:
Cascade to:
  • #COMMUNITYPHARMACISTS#
  • #DISPENSING GP#
  • #HospitalPharmacy#


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency